These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28937145)

  • 1. Immunoreduction of ocular surface tumours with intralesional interferon alpha-2a.
    Kim SE; Salvi SM
    Eye (Lond); 2018 Feb; 32(2):460-462. PubMed ID: 28937145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
    Kim HJ; Shields CL; Shah SU; Kaliki S; Lally SE
    Ophthalmology; 2012 May; 119(5):938-44. PubMed ID: 22361315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant interferon alpha 2b for ocular surface squamous neoplasia: An efficient and cost-effective treatment modality in Asian Indian patients.
    Kaliki S; Singh S; Iram S; Tripuraneni D
    Indian J Ophthalmol; 2016 Oct; 64(10):702-709. PubMed ID: 27905329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional interferon-α for conjunctival mucosa-associated lymphoid tissue lymphoma: long-term results.
    Blasi MA; Tiberti AC; Valente P; Laguardia M; Sammarco MG; Balestrazzi A; Larocca LM; Balestrazzi E
    Ophthalmology; 2012 Mar; 119(3):494-500. PubMed ID: 22226154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alpha-2b in giant ocular surface squamous neoplasia.
    Hernandez-Bogantes E; Serna-Ojeda JC; Lichtinger A; Graue-Hernández EO
    Indian J Ophthalmol; 2016 May; 64(5):393-4. PubMed ID: 27380981
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
    Sturges A; Butt AL; Lai JE; Chodosh J
    Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of efficacy and safety of reconstituted, recombinant human interferon alpha 2b eyedrops without refrigeration as a therapy for immunoreduction and/or treatment of ocular surface squamous neoplasia.
    Kabra NS; Patil VS; Dhanuka DG
    Indian J Ophthalmol; 2021 Dec; 69(12):3776-3777. PubMed ID: 34827049
    [No Abstract]   [Full Text] [Related]  

  • 8. Ocular surface squamous neoplasia treated with topical interferon α 2b.
    Pujari A
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28100578
    [No Abstract]   [Full Text] [Related]  

  • 9. Pegylated Interferon Alpha 2a for the Treatment of Ocular Surface Squamous Neoplasia.
    Park J; Han J; Chung TY; Lim DH; Choi CY
    Cornea; 2022 Oct; 41(10):1271-1275. PubMed ID: 36107845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
    Blasi MA; Maceroni M; Sammarco MG; Pagliara MM
    Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Two cases of conjunctival malignant melanoma treated with topical interferon alpha-2b drop as an adjuvant therapy].
    Kase S; Ishijima K; Noda M; Ishida S
    Nippon Ganka Gakkai Zasshi; 2011 Nov; 115(11):1043-7. PubMed ID: 22171510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreduction of locally advanced orbito-conjunctival squamous cell carcinoma with intraorbital interferon alpha-2b injection: a globe saving approach.
    Meel R; Dhiman R; Sen S; Sharma S
    Clin Exp Ophthalmol; 2018 Jan; 46(1):87-88. PubMed ID: 28570760
    [No Abstract]   [Full Text] [Related]  

  • 13. Intralesional interferon-α for the treatment of bilateral conjunctival mucosa-associated lymphoid tissue lymphoma.
    Holds J; Buchanan A; Hanson R
    Pediatr Blood Cancer; 2012 Jul; 59(1):176-8. PubMed ID: 21793177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of conjunctival squamous neoplasias with interferon alpha 2ab.
    Huerva V; Mangues I
    J Fr Ophtalmol; 2008 Mar; 31(3):317-25. PubMed ID: 18404128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INF α2b for ocular squamous neoplasia.
    Espandar L; Kassem J
    Ophthalmology; 2011 Jul; 118(7):1485; author reply 1485-6. PubMed ID: 21724051
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term follow-up of conjunctival melanoma treated with topical interferon alpha-2b eye drops as adjunctive therapy following surgical resection.
    Kikuchi I; Kase S; Ishijima K; Ishida S
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2271-2276. PubMed ID: 28752368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer classification.
    Shields CL; Kaliki S; Kim HJ; Al-Dahmash S; Shah SU; Lally SE; Shields JA
    Cornea; 2013 Mar; 32(3):248-56. PubMed ID: 22580436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia.
    Kusumesh R; Ambastha A; Kumar S; Sinha BP; Imam N
    Cornea; 2017 Mar; 36(3):327-331. PubMed ID: 28079688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical chemotherapy for ocular surface squamous neoplasia.
    Nanji AA; Sayyad FE; Karp CL
    Curr Opin Ophthalmol; 2013 Jul; 24(4):336-42. PubMed ID: 23680759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon alpha for the treatment of melanocytic conjunctival lesions.
    Herold TR; Hintschich C
    Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):111-5. PubMed ID: 19756691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.